Intracellular replication of Legionella pneumophila. 1981

J A Daisy, and C E Benson, and J McKitrick, and H M Friedman

Legionella pneumophila was inoculated onto tissue culture monolayers of MRC-5, HeLa, Hep 2, and McCoy cells. Fresh and conditioned medium without cells served as controls. Cultures were harvested at various times after inoculation, serial log10 dilutions were performed, and growth of L. pneumophila was quantitated either by direct immunofluorescence or by counting colony-forming units on Feeley-Gorman agar. Growth in monolayers was demonstrated using both techniques. Within 72--96 hr after inoculation, supernatants of infected cells became cloudy, and the cells demonstrated cytopathic changes. In the medium controls, titers of L. pneumophila remained constant by immunofluorescence and declined by counting colonies on agar. When L. pneumophila was inoculated onto monolayers and gentamicin was added 3 hr later, organisms were recovered from the cells but not from supernatants. Transmission electron microscopy revealed intracytoplasmic organisms. These studies indicate that L. pneumophila acts as an intracellular pathogen in tissue cultures, and this characteristic may offer a simple method for studying growth and pathogenicity of this unusual bacillus in humans.

UI MeSH Term Description Entries
D007822 Laryngeal Neoplasms Cancers or tumors of the LARYNX or any of its parts: the GLOTTIS; EPIGLOTTIS; LARYNGEAL CARTILAGES; LARYNGEAL MUSCLES; and VOCAL CORDS. Cancer of Larynx,Laryngeal Cancer,Larynx Neoplasms,Cancer of the Larynx,Larynx Cancer,Neoplasms, Laryngeal,Cancer, Laryngeal,Cancer, Larynx,Cancers, Laryngeal,Cancers, Larynx,Laryngeal Cancers,Laryngeal Neoplasm,Larynx Cancers,Larynx Neoplasm,Neoplasm, Laryngeal,Neoplasm, Larynx,Neoplasms, Larynx
D007875 Legionella Gram-negative aerobic rods, isolated from surface water or thermally polluted lakes or streams. Member are pathogenic for man. Legionella pneumophila is the causative agent for LEGIONNAIRES' DISEASE.
D002583 Uterine Cervical Neoplasms Tumors or cancer of the UTERINE CERVIX. Cancer of Cervix,Cancer of the Cervix,Cancer of the Uterine Cervix,Cervical Cancer,Cervical Neoplasms,Cervix Cancer,Cervix Neoplasms,Neoplasms, Cervical,Neoplasms, Cervix,Uterine Cervical Cancer,Cancer, Cervical,Cancer, Cervix,Cancer, Uterine Cervical,Cervical Cancer, Uterine,Cervical Cancers,Cervical Neoplasm,Cervical Neoplasm, Uterine,Cervix Neoplasm,Neoplasm, Cervix,Neoplasm, Uterine Cervical,Uterine Cervical Cancers,Uterine Cervical Neoplasm
D003470 Culture Media Any liquid or solid preparation made specifically for the growth, storage, or transport of microorganisms or other types of cells. The variety of media that exist allow for the culturing of specific microorganisms and cell types, such as differential media, selective media, test media, and defined media. Solid media consist of liquid media that have been solidified with an agent such as AGAR or GELATIN. Media, Culture
D003588 Cytopathogenic Effect, Viral Visible morphologic changes in cells infected with viruses. It includes shutdown of cellular RNA and protein synthesis, cell fusion, release of lysosomal enzymes, changes in cell membrane permeability, diffuse changes in intracellular structures, presence of viral inclusion bodies, and chromosomal aberrations. It excludes malignant transformation, which is CELL TRANSFORMATION, VIRAL. Viral cytopathogenic effects provide a valuable method for identifying and classifying the infecting viruses. Cytopathic Effect, Viral,Viral Cytopathogenic Effect,Cytopathic Effects, Viral,Cytopathogenic Effects, Viral,Effect, Viral Cytopathic,Effect, Viral Cytopathogenic,Effects, Viral Cytopathic,Effects, Viral Cytopathogenic,Viral Cytopathic Effect,Viral Cytopathic Effects,Viral Cytopathogenic Effects
D005260 Female Females
D005347 Fibroblasts Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules. Fibroblast
D005455 Fluorescent Antibody Technique Test for tissue antigen using either a direct method, by conjugation of antibody with fluorescent dye (FLUORESCENT ANTIBODY TECHNIQUE, DIRECT) or an indirect method, by formation of antigen-antibody complex which is then labeled with fluorescein-conjugated anti-immunoglobulin antibody (FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT). The tissue is then examined by fluorescence microscopy. Antinuclear Antibody Test, Fluorescent,Coon's Technique,Fluorescent Antinuclear Antibody Test,Fluorescent Protein Tracing,Immunofluorescence Technique,Coon's Technic,Fluorescent Antibody Technic,Immunofluorescence,Immunofluorescence Technic,Antibody Technic, Fluorescent,Antibody Technics, Fluorescent,Antibody Technique, Fluorescent,Antibody Techniques, Fluorescent,Coon Technic,Coon Technique,Coons Technic,Coons Technique,Fluorescent Antibody Technics,Fluorescent Antibody Techniques,Fluorescent Protein Tracings,Immunofluorescence Technics,Immunofluorescence Techniques,Protein Tracing, Fluorescent,Protein Tracings, Fluorescent,Technic, Coon's,Technic, Fluorescent Antibody,Technic, Immunofluorescence,Technics, Fluorescent Antibody,Technics, Immunofluorescence,Technique, Coon's,Technique, Fluorescent Antibody,Technique, Immunofluorescence,Techniques, Fluorescent Antibody,Techniques, Immunofluorescence,Tracing, Fluorescent Protein,Tracings, Fluorescent Protein
D005839 Gentamicins A complex of closely related aminoglycosides obtained from MICROMONOSPORA purpurea and related species. They are broad-spectrum antibiotics, but may cause ear and kidney damage. They act to inhibit PROTEIN BIOSYNTHESIS. Gentamicin Sulfate (USP),Gentamycin,G-Myticin,Garamycin,Gentacycol,Gentamicin,Gentamicin Sulfate,Gentamycins,Gentavet,Genticin,G Myticin,GMyticin,Sulfate, Gentamicin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

J A Daisy, and C E Benson, and J McKitrick, and H M Friedman
January 2023, Microbial cell (Graz, Austria),
J A Daisy, and C E Benson, and J McKitrick, and H M Friedman
December 2008, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
J A Daisy, and C E Benson, and J McKitrick, and H M Friedman
September 2005, Infection and immunity,
J A Daisy, and C E Benson, and J McKitrick, and H M Friedman
September 2014, The Biochemical journal,
J A Daisy, and C E Benson, and J McKitrick, and H M Friedman
January 2004, Molecular microbiology,
J A Daisy, and C E Benson, and J McKitrick, and H M Friedman
November 1981, Antimicrobial agents and chemotherapy,
J A Daisy, and C E Benson, and J McKitrick, and H M Friedman
May 2017, Infection and immunity,
J A Daisy, and C E Benson, and J McKitrick, and H M Friedman
November 1999, Microbial pathogenesis,
J A Daisy, and C E Benson, and J McKitrick, and H M Friedman
June 2005, Biochemical and biophysical research communications,
J A Daisy, and C E Benson, and J McKitrick, and H M Friedman
August 2016, FEMS microbiology letters,
Copied contents to your clipboard!